SONUS Pharmaceuticals

SONUS Pharmaceuticals developed proprietary ultrasound contrast agents and drug delivery systems for use in the diagnosis and treatment of heart disease, cancer and other debilitating conditions. IPO (NASDAQ: SNUS).